Welcome to the e-CCO Library!

P0042: Hydrogel-integrated millifluidic system enhances function in primary small intestinal epithelial cells
Year: 2025
Source: ECCO'25
Authors: Alzainx7x7x7 N.(1)*;Almallax7x7x7 A.(2);Gerbethx7x7x7 L.(1);Zieglerx7x7x7 J.(1);Kramerx7x7x7 C.(1);Glaubenx7x7x7 R.(1);Weinhartx7x7x7 M.(2);Siegmundx7x7x7 B.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0043: Fecal extracellular vesicles from healthy individuals: A novel therapeutic approach for patients with Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Ghandianx7x7x7 A.(1)*;Heydarix7x7x7 R.(2);Shahrokhx7x7x7 S.(3);Meyfourx7x7x7 A.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0044: What are the similarities between primary immunodeficiency states and ulcerative colitis: damage to the microbiomex7x7x7 impaired mucosal secretion of proteins and short-chain fatty acidsx7x7x7 or something else?
Year: 2025
Source: ECCO'25
Authors: Iakovlevx7x7x7 A.A.(1);Bashtovayax7x7x7 O.(2)*;Volkovx7x7x7 A.(2);Tarasovax7x7x7 G.(2);Nukhovax7x7x7 S.(2);Zubovax7x7x7 A.(2);Piskovetsx7x7x7 V.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0045: Serologic levels of fatty acids as promising biomarkers for the severity of Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Cejudo-Garcésx7x7x7 A.(1)*;Patelx7x7x7 J.(1);Jarénx7x7x7 A.(1);Macias-Cejax7x7x7 D.(1);Boscá-Wattsx7x7x7 M.M.(2);Boronatx7x7x7 L.(2);Calatayudx7x7x7 S.(1x7x7x73);Barrachinax7x7x7 M.D.(1x7x7x73);Ortiz-Masiáx7x7x7 D.(3x7x7x74x7x7x75);Cosín-Rogerx7x7x7 J.(1x7x7x73);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0046: Proteomic Profiles Associated with Residual Ultrastructural Anomalies in the Epithelium of IBD patients in Endoscopic Remission
Year: 2025
Source: ECCO'25
Authors: Meuwisx7x7x7 M.A.(1x7x7x72)*;Lolyx7x7x7 J.P.(3);Saléex7x7x7 C.(2);Massotx7x7x7 C.(2x7x7x74);Baiwirx7x7x7 D.(5);Fléronx7x7x7 M.(6);Mazzucchellix7x7x7 G.(7);Vieujeanx7x7x7 S.(2x7x7x78x7x7x79);Somjax7x7x7 J.(10);Louisx7x7x7 E.(2x7x7x711);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0047: Understanding the pathogenic role of inflammatory fibroblasts in Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Matellanx7x7x7 C.(1);Nwaezeigwex7x7x7 M.(2)*;Dohertyx7x7x7 G.(3);Manresax7x7x7 M.(4);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0048: Alterations in circulating T-cell subpopulations reflect disease activity in Ulcerative Colitis
Year: 2025
Source: ECCO'25
Authors: Profetax7x7x7 F.(1)*;Rumix7x7x7 G.(1);Notarnicolax7x7x7 D.(1);Capobiancox7x7x7 I.(1);Masix7x7x7 L.(1);Emolix7x7x7 V.(1);Troisix7x7x7 S.(1);Varuolox7x7x7 M.M.(1);Turchinix7x7x7 L.(1);Lopetusox7x7x7 L.R.(2);Laterzax7x7x7 L.(1);Pugliesex7x7x7 D.(3);Papax7x7x7 A.(4);Gasbarrinix7x7x7 A.(4);Petitox7x7x7 V.(1);Scaldaferrix7x7x7 F.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0049: Bile acid profiling of ileal fluid in Crohn’s disease using metabolomics
Year: 2025
Source: ECCO'25
Authors: De Greefx7x7x7 I.(1)*;Loopmansx7x7x7 S.(2);Bislenghix7x7x7 G.(3);D'Hoorex7x7x7 A.(3);Terrassonx7x7x7 I.(3);Verstocktx7x7x7 B.(4);Sabinox7x7x7 J.(4);Ferrantex7x7x7 M.(4);Ghesquièrex7x7x7 B.(2);Vermeirex7x7x7 S.(4);Verstocktx7x7x7 S.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P004: Altered colonic mucosal oxylipins and endocannabinoids levels in treatment-naive and deep remission ulcerative colitis patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Diab1*, S. Gouveia2, T. Hansen1, E. Jensen1, T. Moritz2, R. Goll3, J. Florholmen3, G. Forsdahl1

Created: Thursday, 21 February 2019, 9:14 AM
P004: Critical paralog proteins has a cell-type specific rewiring role in Ulcerative Colitis associated signalling processes
Year: 2021
Source: ECCO'21 Virtual
Authors: Kornilova, P.(1);Potari-Gul, L.(1);Modos, D.(1,2);Madgwick, M.(1,2);Haerty, W.(1);Korcsmaros, T.(1,2);
Created: Wednesday, 2 June 2021, 4:12 PM
P004: Exon-level microarrays identify alternative splicing for ICAM3 in Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Verstockt*1, M. Vancamelbeke2, B. Verstockt2, F. Schuit3, M. Ferrante2, S. Vermeire2, I. Cleynen1, I. Arijs2

Created: Friday, 22 February 2019, 9:49 AM
P004: IL-22 affects barrier function and cell polarity by MAPK/PI3 kinase signal transduction
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

D. Delbue da Silva*1, L. Lebenheim1, C. Heldt1, B. Siegmund1, M. Schumann1

Created: Friday, 22 February 2019, 9:41 AM
P004: Microbiota, not host origin drives ex vivo epithelial response in ulcerative colitis patients and non-IBD controls.
Year: 2022
Source: ECCO'22
Authors: Arnauts, K.(1);Sudhakar, P.(1);Verstockt, S.(1);Lapierre, C.(1);Potche, S.(1);Caenepeel, C.(1);Verstockt, B.(1,2);Raes, J.(3);Vermeire, S.(1,2);Sabino, J.(1,2);Verfaillie, C.(4);Ferrante, M.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
P004: Stimulation of CYP450-mediated ω-3 docosahexaenoic acid metabolism via MFSD2A as a novel therapy for inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ungaro F.*1,2, Tacconi C.3, Correale C.4, Massimino L.5, Corsetto P.6, Piontini A.2,4, Fonteyne P.7, Calcaterra F.8, Della Bella S.8, Spinelli A.8, Carvello M.8, Rizzo A.6, Vetrano S.2,4, Fiorino G.4,8, Furfaro F.4,8, Maddipati K.R.9, D'Alessio S.4,10, Danese S.2,4

Created: Wednesday, 20 February 2019, 10:36 AM
P004: Untargeted serum metabolome shows Crohn Disease (CD) associated signature, signals that correlate with disease activity and CRP, and signals that may precede disease flare
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Levhar, N.(1)*;Hadar, R.(1);Braun, T.(1);Efroni, G.(1);Abramovich, I.(2);Gottlieb, E.(2);Granot, M.(1);Sandra, N.(3);Selinger, L.(3);Picard, O.(3);Yavzori, M.(3);Lahat, A.(3);Eliakim, R.(3);Weiss, B.(1);Kopylov, U.(3);Ben-Horin, S.(3);Amir, A.(1);Haberman Ziv, Y.(1);
Created: Friday, 14 July 2023, 10:43 AM
P005 Regulators of the guanylate cyclase pathway are potential novel markers of mucosal healing in IBD
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L.E. Jeffery1, U.N. Shivaji1, D. Zardo2, A. Acharjee3, O.M. Nardone4, S.C. Smith4, G. Gkoutos3, S.S. Visweswariah5, S. Ghosh1, M. Iacucci1

Created: Thursday, 30 January 2020, 10:12 AM
P0050: 4-Octyl Itaconate Protects Against Colitis by Modulating Neutrophil Function and Enhancing Intestinal Epithelial Barrier Integrity
Year: 2025
Source: ECCO'25
Authors: Guox7x7x7 M.(1)*;Lingjuanx7x7x7 J.(2);Ruanx7x7x7 G.(1);Runingx7x7x7 Z.(1);Yiqunx7x7x7 G.(3);Hongx7x7x7 Y.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0051: Is NKCC1x7x7x7 a marker of dysplasia associated with inflammation and CACx7x7x7 playing a role in colorectal carcinogenesis?
Year: 2025
Source: ECCO'25
Authors: Adamx7x7x7 P.(1)*;Saléex7x7x7 C.(1);Stepniak x7x7x7 M.(1);Lolyx7x7x7 J.P.(2);Vieujeanx7x7x7 S.(1x7x7x72x7x7x73);Reenaers x7x7x7 C.(2);Coimbrax7x7x7 C.(4);Deckerx7x7x7 E.(4);Massotx7x7x7 C.(1x7x7x72);Delvennex7x7x7 P.(5);Louisx7x7x7 E.(1x7x7x72);Meuwisx7x7x7 M.A.(1x7x7x72);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0052: Enhancing gut epithelial integrity and reducing epithelial inflammation through supplementation of fecal metabolitesx7x7x7 guided by novel ex vivo functional prioritization and testing
Year: 2025
Source: ECCO'25
Authors: Elwahidi x7x7x7 L.(1);Abbas-Egbariya x7x7x7 H.(1);Braun x7x7x7 T.(1);Amir x7x7x7 A.(1);Haberman x7x7x7 Y.(1)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0053: Microscopic colitis: analysis of microbiota changes in different segments of the colon and terminal ileum.
Year: 2025
Source: ECCO'25
Authors: Kiudelisx7x7x7 V.(1x7x7x72)*;Alzbutasx7x7x7 G.(2);Karaliutex7x7x7 I.(2);Lukoseviciusx7x7x7 R.(2);Bernerienex7x7x7 N.(2);Skiecevicienex7x7x7 J.(2);Kupcinskasx7x7x7 J.(1x7x7x72);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session